Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies

Christa Dijkhuizen; Patrick  Korthuis; Cristina Aguado; Silvia Garcia-Román; Andrés Aguilar-Hernández; Lyndsay Drayer; Margot De Looff; Fin Milder; Anthonie van der Wekken; Anke van den Berg

Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies

Christa Dijkhuizen (First author)
, Patrick Korthuis
, Cristina Aguado
, Silvia Garcia-Román
, Andrés Aguilar-Hernández
, Lyndsay Drayer
, Margot De Looff
, Fin Milder
, Anthonie van der Wekken
, Anke van den Berg

Biomolecules & Health

Dexeus University Hospital, Pangaea Oncology
Quirón Dexeus University Hospital, Dr Rosell Oncology Institute
University of Groningen, University Medical Center Groningen, Department of Pulmonology
University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology

Research output: Contribution to conference › Abstract › Academic

152 Downloads (Pure)

Original language	English
Number of pages	2
Publication status	Published - 13 Jun 2025
Event	European Association for Cancer Research 2025 - Lisbon, Portugal Duration: 16 Jun 2025 → 19 Jun 2025

Conference

Conference	European Association for Cancer Research 2025
Abbreviated title	EACR2025
Country/Territory	Portugal
City	Lisbon
Period	16/06/25 → 19/06/25

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 03 Good Health and Well-being

Keywords

ROS1
ROS1 inhibitors
patient derived cell lines

Research Focus Areas Hanze University of Applied Sciences * (mandatory by Hanze)

Healthy Ageing

Research Focus Areas Research Centre or Centre of Expertise * (mandatory by Hanze)

Medical Diagnostics & Point of Care Testing
Healthcare & Biotechnology

Publinova themes

Health

Access to Document

abstract EACR Lisbon C.O.DijkhuizenSubmitted manuscript, 712 KB

Cite this

@conference{2b3b14d88a044475b2e8ba201d20d7ba,

title = "Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies",

keywords = "ROS1, ROS1-remmers, cellijnen afkomstig van pati{\"e}nten, ROS1, ROS1 inhibitors, patient derived cell lines",

author = "Christa Dijkhuizen and Patrick Korthuis and Cristina Aguado and Silvia Garcia-Rom{\'a}n and Andr{\'e}s Aguilar-Hern{\'a}ndez and Lyndsay Drayer and \{De Looff\}, Margot and Fin Milder and \{van der Wekken\}, Anthonie and \{van den Berg\}, Anke",

year = "2025",

month = jun,

day = "13",

language = "English",

note = "European Association for Cancer Research 2025 ; Conference date: 16-06-2025 Through 19-06-2025",

}

TY - CONF

T1 - Assessment of two new ROS1+ NSCLC patient-derived cell lines as in vitro models for TKI resistance studies

AU - Dijkhuizen, Christa

AU - Korthuis, Patrick

AU - Aguado, Cristina

AU - Garcia-Román, Silvia

AU - Aguilar-Hernández, Andrés

AU - Drayer, Lyndsay

AU - De Looff, Margot

AU - Milder, Fin

AU - van der Wekken, Anthonie

AU - van den Berg, Anke

PY - 2025/6/13

Y1 - 2025/6/13

KW - ROS1

KW - ROS1-remmers

KW - cellijnen afkomstig van patiënten

KW - ROS1

KW - ROS1 inhibitors

KW - patient derived cell lines

M3 - Abstract

T2 - European Association for Cancer Research 2025

Y2 - 16 June 2025 through 19 June 2025

ER -